|Medclean expands market opportunity|
|By Staff and Wire Reports|
|Tuesday, 16 March 2010 09:35|
MedClean Technologies, Inc., (OTC Bulletin Board: MCLN) the leading provider of onsite technology for the treatment and disposal of medical waste and the destruction of confidential documents and related media, today announced the expansion of its MedClean Container/Mobile Series product line designed to increase the Company's market opportunity.
Traditionally, the Company has provided its technology to large quantity generators (LQGs) with a focus on hospitals of 300 beds or greater. With the introduction of the MedClean 4100/MC4200 the Company is now positioned to expand its market share by providing packaged solutions and value-based pricing to a broader market. This new product will enable smaller hospitals to benefit through the Company's 25% savings program, which offers savings compared to traditional medical waste hauling alternatives utilized today. In addition, these products will allow the Company to address the needs of extensive hospital networks and Group Purchasing Organizations (GPOs) that service a mix of large and small hospitals more cost effectively. Lastly, these products will be sold through MedClean's new distributor and manufacturer's representative network to expedite product launch and to accelerate the company's penetration into the market. This line extension increases MedClean's addressable market by over 6,000 possible locations in North America alone.
"Expanding our product line to satisfy the needs of our significant network opportunities as well as expanding our channels of distribution with prepackaged solutions is essential for delivering value for our clients and our shareholders," commented Dave Laky, President and CEO. "These packaged solutions are a precursor to a ground-breaking technology for departmental use that the Company plans to introduce later in the year. These solutions offered to an expanding addressable market of over two hundred thousand medical waste generators will further enable MedClean to achieve its objective for more than 100% compounded annual revenue growth over the next five years."